Adaptimmune Therapeutics plc

  • Home
  • Our Company
    • Overview arrow_forward
    • Partners arrow_forward
    • Board of Directors arrow_forward
    • Leadership Team arrow_forward
    • Scientific Advisory Board arrow_forward
    • Perspectives arrow_forward
  • Pipeline
    • Clinical Pipeline arrow_forward
    • Afami-cel arrow_forward
    • ADP-A2M4CD8 arrow_forward
    • Preclinical Pipeline arrow_forward
  • Technology
    • Overview arrow_forward
    • Manufacturing arrow_forward
    • Publications arrow_forward
  • Patients & Families
    • Overview arrow_forward
    • Taking Part in Our Clinical Trials arrow_forward
    • Cancer Info arrow_forward
    • Cancer Immunotherapy Month arrow_forward
    • Videos arrow_forward
    • Engagement with Patient Organizations arrow_forward
  • Clinical Trials
    • Overview arrow_forward
    • Expanded Access Policy arrow_forward
  • Investors & Media
    • Overview arrow_forward
    • News Center arrow_forward
    • Financial Info and Governance arrow_forward
    • Stock Data arrow_forward
    • SEC Filings arrow_forward
  • Contact
  • Careers
    • Overview arrow_forward
    • US Careers arrow_forward
    • UK Careers arrow_forward

Corporate Presentations

Investors & Media

Investors & Media

  • Overview
  • News Center
    • Media
    • Corporate Presentations
    • Press Releases
    • Publications
    • Events
    • Email Alerts
  • Financial Info and Governance
    • Company Information
    • Leadership Team
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Annual Shareholder Meeting
    • FAQ
    • Contacts
    • Adaptimmune Ltd Report
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • News Center

  • Media
  • Corporate Presentations
  • Press Releases
  • Publications
  • Events
  • Email Alerts
May 2022 Corporate Deck
May 20, 2022

May 2022 Corporate Deck

April 2022 Corporate Deck
Apr 14, 2022

April 2022 Corporate Deck

March 2022 Corporate Deck
Mar 25, 2022

March 2022 Corporate Deck

January 2022 Corporate Deck
Jan 10, 2022

January 2022 Corporate Deck

October 2021 Corporate Deck
Oct 1, 2021

October 2021 Corporate Deck

SURPASS ESMO poster September 16th, 2021th
Sep 16, 2021

SURPASS ESMO poster September 16th, 2021th

Video Presentation of: Building a cell therapy franchise: SURPASS Phase 1 trial data at ESMO September 13, 2021
Sep 13, 2021

Video Presentation of: Building a cell therapy franchise: SURPASS Phase 1 trial data at ESMO September 13, 2021

Presentation deck for Building a cell therapy franchise: SURPASS Phase 1 trial data at ESMO September 13, 2021
Sep 13, 2021

Presentation deck for Building a cell therapy franchise: SURPASS Phase 1 trial data at ESMO September 13, 2021

Replay of First live virtual event – our allogeneic platform
Sep 9, 2021

Replay of First live virtual event – our allogeneic platform

Presentation deck for First live virtual event – our allogeneic platform
Sep 9, 2021

Presentation deck for First live virtual event – our allogeneic platform

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next »
Adaptimmune Therapeutics plc
Privacy Policy Disclaimer Search Sitemap Terms of Use Supply Terms Cookie Policy Manage Cookie Preferences
Linedin Twitter Youtube
© 2022 Adaptimmune Therapeutics plc. All Rights Reserved.